Drug
Aconitum Nap, Arsenicum Alb, Borax, Calc Phos, Gelsenium, Lycopodium, Phosphoricum Ac, Picricum Ac, Plumb Met, Solidago
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Electrolyte Imbalance | 7 | 22.3 | 22.5 | signal |
| 2 | Hypercalcaemia | 7 | 20.8 | 21.0 | signal |
| 3 | Brain Oedema | 6 | 17.4 | 17.6 | signal |
| 4 | Injection Site Irritation | 6 | 17.4 | 17.5 | signal |
| 5 | Mydriasis | 6 | 17.1 | 17.3 | signal |
| 6 | Impaired Quality Of Life | 6 | 15.3 | 15.4 | signal |
| 7 | Poor Quality Product Administered | 4 | 14.3 | 14.4 | signal |
| 8 | Ear Discomfort | 4 | 14.3 | 14.4 | signal |
| 9 | Product Use Complaint | 6 | 14.2 | 14.3 | signal |
| 10 | Blood Triglycerides Increased | 6 | 12.4 | 12.5 | signal |
| 11 | Eructation | 6 | 11.5 | 11.7 | signal |
| 12 | Eye Discharge | 3 | 10.7 | 10.8 | signal |
| 13 | Poor Venous Access | 3 | 10.6 | 10.7 | signal |
| 14 | Product Preparation Error | 6 | 10.6 | 10.7 | signal |
| 15 | Hereditary Angioedema | 3 | 10.5 | 10.5 | signal |
| 16 | Myelosuppression | 9 | 9.7 | 9.8 | signal |